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--12 n l 84 20 47.6 35.2 966 100 A1 so, pre-C f a s t i n g induced marked C6-10 dicarboxyl i c a c i d u r i a accompanied by accumulation o f C10-14 f a t t y acids i n plasma. On C, u r i n a r y d i c a r b o x y l i c acids peaked a t <20% o f pre-C l e v e l s w i t h l i t t l e o r no accumulation of C10-14 f a t t y acids i n plasma.
We conclude on lucone g e n e 7 f r i~ a l a n i n e ($la) were i n v e 5 t i g a t e d ~n w e l l Tc] and r a ? n o u r ? s h d (M) r a t s . S~x t y t o 80 g Wlstar r a t s were made M by feeding a 4 % p r o t e i n ( P r t ) , 54% carbohydrate (Cho) d i e t f o r 4 weeks. C were f e d a d f e t w i t h 224 P r t and 63% Cho. Both arouos received ecual amounts o f f a t . vitamins and minerals. i f t e r an-overnight f a s t t h e r a t s received a s i n g l e i.p. dose o f Ala ( 1 g/kg), w i t h o r w i t h o u t p r i o r priming w i t h 2 g/kg G3P. 30 min before Ala. Flood glucose (Glc) l e v e l s were monitored f o r 2 h r and noted as changes over baseline. The r e s u l t s i n d i c a t e :
(1) Both groups o f r a t s produced Glc from Ala a t t h e same r a t e (F=2.89; df=1,60; NS). (2) When G3P was i n j e c t e d before Ala, blood Glc declined i n M r a t s t o l e v e l s below baseline beginn i n g 60 min a f t e r Ala a d m i n i s t r a t i o n (FzE9.8; df=1,60; PtO.OO1, compared t o A.la alone). C r a t s had no i n h i b i t i o n o f Glc f o rmaticn by G3P. Conclusions: i n M r a t s , G3P a d m i n i s t r a t i o n i nh i b i t s normal gluconeogenesis from Ala, i n c o n t r a s t t o C r a t s . i n which both substrates show no i n t e r a c t i o n . Therefore, these data support t h e view t h a t n u t r i t i o n a l s t a t u s may p l a y a r o l e i n tolerance t o g l y c e r o l , t h e n~e t a b o l i c precursor o f 6?P, esp e c i a l l y e a r l y i n l i f e . I studied the developmental p r o f i l e o f glycogen, glycogen synthase and phosphorylase i n l i v e r s o f c o n t r o l f e t a l lambs a t 123, 131, and 142d g e s t a t i o n (term 150d) and i n the l i v e r s o f t h e i r twins given intravenous glucose (16i2 mg/kg/min, M+SE) from 112d onwards.
GLYCOGEN IN FETAL LAMB LIVER I S INCREASED DURING
Serum glucose ( 3 4 i 2 m g l d l ) and i n s u l i n (47+11 uU/ml) i n the glucose t r e a t e d fetuses were higher than serum glucose (19+3 mg/dl , P < 0.01) and i n s u l i n (14+2 ~U / m l , P < 0.01) i n the c o n t r o l s . To investigate the acute effects of CHL on energy metabolism we have studied its effects on oxidative activity in isolated mitochondria from adult rat and newborn pig hearts. We have previously shown acutely reduced myocardial function in newborn pig hearts in the presence of CHL. Respiratory substrates provided were pyruvate(PYR)/malate(MAL) 7.1/4.7mM, glutamate(GLU) 18mM, durohydroquinone(DHQ) 1.62mM, a-ketoglutarate(AKG) 5mM, and succinate(SUC) 10mM. State 3(ADP-stimulated) oxidation of PYR, MAL, GLU, and DHQ was unaffected or only mildly affected in the presence of CHL concentrations as high as 500 uglml. Oxidation of AKG and SUC was inhibited 39 and 55% respectively in rat and to a similar degree in pig heart by 50 pg/ml CHL. State 4 oxidation was relatively unaffected. SUC oxidation was also observed in sonicated mitochondria and was unaffected by CHL, suggestingthat transport was the limiting factor in SUC oxidation. Measurement of SUC accumulation in mitochondria showed transport to be reduced 75-84% in the presence of CHL (500 uglml). Studies in the presence of phthalonate indicated that succinate is primarily transported by the AKG carrier in the heart. CHL also inhibited mitochondria1 AKG release in the presence of MAL and GLU indicating impairment of the malatelaspartare shuttle by CHL. Impairment of the malatelaspartate shuttle resulting from inhibition of the AKG carrier may contribute to the acute clinical toxicity of CHL. Muscle carnitine transferase a c t i v i t y was elevated. To determine 1) i f i n v i m P-31 NMR ~p e c t r o s c q y could detect a metabolic abnormality i n hnywardium, and 2) i f P-31 NMR could be used to evaluate therapy designed to inprove mymardial energy production, masrnements were mde using a 1MR-32 Oxford Research Systems mgnet (30 an b r e , 1.9 Tesla) with a 5 an surface c o i l ~o s i t i o n e d over the sternum. This dermnstrated an abnormally lm phosphocreatine/hrganic phosphate r a t i o (PCr/P. ) mmpared to w n t r o l (1.0+0.05 vs 2.0t0.3, Rc0.01) . PCr/Pi r e d i n e d low i n t k fastinq stac& with o r without alhninistered W I o i l , but im pmved substantially following I.V. glucose o r a carbohydrate enriched ml (PCr/Pi = 1.8+0.1, not different from w n t r o l ) . We conclude t h a t P-31 NMR can be used to evaluate the high energy pbsphate profile of the h m heart. F u r t h e m r e , !&en used i n wnjunction with dietary mnipulations, it can be used to op- 
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Childrents Hospital, Univ. of Cincinnati Pulmonary glycogen serves as substrate for surfactant lipid synthesis by Type I1 cells during the perinatal period. Glycogen is depleted from these cells in association with activation of phosphorylase (phos b ) . Phos b is phosphorylated to phos a by phosphorylase kinase (PK). The present study tests the hypothesis that known depletion of pulmonary glycogen is associated with ontogenic changes in PK. Lung PK wak quantitated by phosphorylation of endogenous and exogeneous phos b assessed by SDS-PAGE and autoradiography. 3 2~-~h o s a was the major ca2+-dep phospho-protein in fetal lung cytosol by 2-D, IEF-PAGE, co-migrating with purified muscle enzyme. PK increased from day 17 to 20-21 gestation declining to undetectable levels wtthin a week of age. PK was ca2+-dependent, ECsO ca2+ ~o-'M. Exogenous phos b w s readily phosphorylated by fetal but not adult cytosol. Added purified exogenous PK did not enhance 32~-phos a in postnatal lung. PK was also demonstrated in purified Type I1 cells from rat. Activity was highest 16 hrs after isolation, decreasing during culture 3-4d. Conclusion: phosphorylase kinase activity was identified in cytosol from both Type I1 cells and fetal lung. PK increases prior to birth and decreases dramatically postnatally. Decreases in both phos b (substrate) and phosphorylase kinase may account for known postnatal decreases in phos a activity. High PK activity is associated wLth glycogen depletion and surfactant synthesis in the Type I1 cells at 20-21d gestation in the rat.
